FDA
Cefpodoxime Proxetil
The FDA lists this product in 16 strengths and forms.
Composition
- Active ingredients
- CEFPODOXIME PROXETIL EQ 100MG BASE/5ML
Strengths and forms
The FDA lists each strength of a product separately; these pages share one label.
- CEFPODOXIME PROXETIL EQ 100MG BASE · TabletANDA065462-001 · Prescription
- CEFPODOXIME PROXETIL EQ 200MG BASE · TabletANDA065462-002 · Prescription
- CEFPODOXIME PROXETIL EQ 50MG BASE/5ML · For suspensionANDA065082-001 · Discontinued
- CEFPODOXIME PROXETIL EQ 100MG BASE/5ML · For suspensionANDA065082-002 · Discontinued
- CEFPODOXIME PROXETIL EQ 50MG BASE/5ML · For suspensionANDA065409-001 · Prescription
- CEFPODOXIME PROXETIL EQ 100MG BASE/5ML · For suspensionANDA065409-002 · Prescription
- CEFPODOXIME PROXETIL EQ 100MG BASE/5ML · For suspensionThis page
- CEFPODOXIME PROXETIL EQ 50MG BASE/5ML · For suspensionANDA090031-001 · Discontinued
- CEFPODOXIME PROXETIL EQ 200MG BASE · TabletANDA065083-002 · Discontinued
- CEFPODOXIME PROXETIL EQ 100MG BASE · TabletANDA065083-001 · Discontinued
- CEFPODOXIME PROXETIL EQ 200MG BASE · Tablet
At a glance
- Brand name
- Cefpodoxime Proxetil
- Route
- Oral
- Dosage form
- For suspension
- Applicant
- Chartwell RX
- Status
- Discontinued
- FDA approval
- 14 Jan 2009
- Application
- ANDA090031-002